Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Signed Informed Consent;
Adults Male and Female ≥ 18 years old;
Obesity (BMI ≥ 30kg/m2 or ≥ 27 Kg/m2 with associate risk);
Pregnancy and Lactation or women without effective contraception;
Relevant clinical diseases;
Obesity associated to genetic syndrome;
Use of: anorectics, herbal weight loss and/or constipation and laxatives, in the past 30 days;
Patients using cyclosporine or amiodarone;
Patients with bowel disease;
Prior bariatric surgery;
Hemoglobinopathies and coagulopathy;
History of cancer in the past five years;
Use of corticosteroids, oral or injectable, in the last 30 days.